373 related articles for article (PubMed ID: 29732913)
1. Augmentation strategies for clozapine refractory schizophrenia: A systematic review and meta-analysis.
Siskind DJ; Lee M; Ravindran A; Zhang Q; Ma E; Motamarri B; Kisely S
Aust N Z J Psychiatry; 2018 Aug; 52(8):751-767. PubMed ID: 29732913
[TBL] [Abstract][Full Text] [Related]
2. Augmentation Strategies for Clozapine-Resistant Patients with Schizophrenia.
Chiu YH; Hsu CY; Lu ML; Chen CH
Curr Pharm Des; 2020; 26(2):218-227. PubMed ID: 31924152
[TBL] [Abstract][Full Text] [Related]
3. Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine.
Muscatello MR; Bruno A; De Fazio P; Segura-Garcia C; Pandolfo G; Zoccali R
Expert Opin Pharmacother; 2014 Nov; 15(16):2329-45. PubMed ID: 25284216
[TBL] [Abstract][Full Text] [Related]
4. Clozapine augmentation strategies - a systematic meta-review of available evidence. Treatment options for clozapine resistance.
Wagner E; Löhrs L; Siskind D; Honer WG; Falkai P; Hasan A
J Psychopharmacol; 2019 Apr; 33(4):423-435. PubMed ID: 30696332
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of aripiprazole augmentation of clozapine in schizophrenia: a systematic review and meta-analysis of randomized-controlled trials.
Srisurapanont M; Suttajit S; Maneeton N; Maneeton B
J Psychiatr Res; 2015 Mar; 62():38-47. PubMed ID: 25619176
[TBL] [Abstract][Full Text] [Related]
6. CBTp for people with treatment refractory schizophrenia on clozapine: a systematic review and meta-analysis.
Todorovic A; Lal S; Dark F; De Monte V; Kisely S; Siskind D
J Ment Health; 2023 Feb; 32(1):321-328. PubMed ID: 33076721
[TBL] [Abstract][Full Text] [Related]
7. [Augmentation strategies in patients with schizophrenia who show partial response to clozapine treatment].
Vayısoğlu S; Anıl Yağcıoğlu E
Turk Psikiyatri Derg; 2014; 25(3):201-11. PubMed ID: 25219694
[TBL] [Abstract][Full Text] [Related]
8. Augmentation strategies in clozapine-resistant schizophrenia.
Remington G; Saha A; Chong SA; Shammi C
CNS Drugs; 2005; 19(10):843-72. PubMed ID: 16185094
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
[TBL] [Abstract][Full Text] [Related]
10. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
11. Optimal Treatment Strategies of Clozapine for Refractory Schizophrenia.
Li YY; Zhang YS; Wang J; Li KQ; Wang HY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Dec; 38(6):666-678. PubMed ID: 28065233
[TBL] [Abstract][Full Text] [Related]
12. Is electroconvulsive therapy effective as augmentation in clozapine-resistant schizophrenia?
Kittsteiner Manubens L; Lobos Urbina D; Aceituno D
Medwave; 2016 Oct; 16(Suppl5):e6577. PubMed ID: 27813505
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological and nonpharmacological augmentation treatments for clozapine-resistant schizophrenia: A systematic review and network meta-analysis with normalized entropy assessment.
Yeh TC; Correll CU; Yang FC; Chen MH; Tseng PT; Hsu CW; Carvalho AF; Stubbs B; Thompson T; Chu CS; Yu CL; Il Shin J; Yang SN; Tu YK; Liang CS
Asian J Psychiatr; 2023 Jan; 79():103375. PubMed ID: 36470132
[TBL] [Abstract][Full Text] [Related]
14. Design and protocol for the Focusing on Clozapine Unresponsive Symptoms (FOCUS) trial: a randomised controlled trial.
Pyle M; Norrie J; Schwannauer M; Kingdon D; Gumley A; Turkington D; Byrne R; Syrett S; MacLennan G; Dudley R; McLeod HJ; Griffiths H; Bowe S; Barnes TR; French P; Hutton P; Davies L; Morrison AP
BMC Psychiatry; 2016 Aug; 16():280. PubMed ID: 27496180
[TBL] [Abstract][Full Text] [Related]
15. Augmentation strategies of clozapine with antipsychotics in the treatment of ultraresistant schizophrenia.
Mouaffak F; Tranulis C; Gourevitch R; Poirier MF; Douki S; Olié JP; Lôo H; Gourion D
Clin Neuropharmacol; 2006; 29(1):28-33. PubMed ID: 16518132
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of lamotrigine in clozapine-resistant schizophrenia: a systematic review and meta-analysis.
Tiihonen J; Wahlbeck K; Kiviniemi V
Schizophr Res; 2009 Apr; 109(1-3):10-4. PubMed ID: 19186030
[TBL] [Abstract][Full Text] [Related]
17. Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial.
Chang JS; Ahn YM; Park HJ; Lee KY; Kim SH; Kang UG; Kim YS
J Clin Psychiatry; 2008 May; 69(5):720-31. PubMed ID: 18370574
[TBL] [Abstract][Full Text] [Related]
18. Clozapine Combination and Augmentation Strategies in Patients With Schizophrenia -Recommendations From an International Expert Survey Among the Treatment Response and Resistance in Psychosis (TRRIP) Working Group.
Wagner E; Kane JM; Correll CU; Howes O; Siskind D; Honer WG; Lee J; Falkai P; Schneider-Axmann T; Hasan A;
Schizophr Bull; 2020 Dec; 46(6):1459-1470. PubMed ID: 32421188
[TBL] [Abstract][Full Text] [Related]
19. Clozapine and Psychosocial Function in Schizophrenia: A Systematic Review and Meta-Analysis.
Olagunju AT; Clark SR; Baune BT
CNS Drugs; 2018 Nov; 32(11):1011-1023. PubMed ID: 30155842
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive second-generation antipsychotics for specific symptom domains of schizophrenia resistant to clozapine: A meta-analysis.
Bartoli F; Crocamo C; Di Brita C; Esposito G; Tabacchi TI; Verrengia E; Clerici M; Carrà G
J Psychiatr Res; 2019 Jan; 108():24-33. PubMed ID: 30447508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
